SHILPAMED

Shilpa Medicare Ltd.

930.00-32.1 (-3.34%)
15 Oct, 10:29 AM

Annual Reports and Financial Documents

Shilpa Medicare Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Shilpa Medicare Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General10 Oct 2026
    Europe GMP Approval Of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana.
    Europe GMP approval of Shilpa Medicare Limited. Unit 4, Jadcherla, Telangana.
  2. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018
  3. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201126 Sept 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 26, 2026 for Ramakant Innani & Others
  4. Closure of Trading Window25 Sept 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window
  5. General23 Sept 2026
    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Assignment Of ESG Rating By CRISIL ESG Ratings.
    Assignment of ESG Ratings by CRISIL ESG Ratings
  6. Analyst / Investor Meet22 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Investors/Analysts meet
  7. General18 Sept 2026
    USFDA Inspection Of Shilpa Medicare Limited, Unit VII, Analytical Services Division, Hyderabad.
    USFDA Inspection of Shilpa Medicare Limited at Unit VII, Analytical Services Division, Hyderabad.
  8. AGM12 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Submission of Scrutinizers Report on 39th AGM Resolutions along with Voting Results
  9. Press Release / Media Release11 Sept 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Shilpa Medicare''s Novel Complex Injectable OERIS (Ondansetron Extended - Release Injection, 100 mg/mL) receives final approval from Subject Expert Committee (SEC) for grant of marketing ....
  10. AGM11 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceedings of 39th Annual General Meeting.
  11. General10 Sept 2026
    Initiation Of NCLT Order On FTF Pharma Private Limited, A Wholly Owned Subsidiary Of Shilpa Medicare Limited.
    Initiation of NCLT Order on FTF Pharma Private Limited, a Wholly Owned Subsidiary of Shilpa Medicare Limited.
  12. General19 Aug 2026
    Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent /Depository Participants
    Dispatch of letter to shareholders whose e-mail addresses are not registered with Company/ Registrar & Transfer Agent/ Depository Participants.
  13. General18 Aug 2026
    Response On The News Item Captioned 'Shilpa Medicare Recalls Over 27K Vials Of Chemotherapy Drug In US' Published In The Online Edition Of The Economic Times On August 17, 2026 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
    Disclosure under Reg.30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
  14. Dividend Updates17 Aug 2026
    Announcement under Regulation 30 (LODR)-Dividend Updates
    Dividend Update
  15. Newspaper Publication14 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication
  16. Reg. 34 (1) Annual Report13 Aug 2026
    Reg. 34 (1) Annual Report.
    Annual Report of Shilpa Medicare Limited for the FY 2025-26
  17. AGM13 Aug 2026
    39Th Annual General Meeting Notice
    39th Annual General Meeting Notice
  18. Analyst / Investor Meet5 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio link of the Investor Conference call for Q1 FY27
  19. Record Date5 Aug 2026
    Final Dividend For The FY 2025-26
    The record date for determining the shareholders entitled for payment of final dividend for FY 2025-26, if declared at the 39th AGM is Friday, 4th September 2026.
  20. Outcome of Board Meeting5 Aug 2026
    Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended 30 June, 2026
    Unaudited Financial Results for the Quarter ended 30 June 2026

Frequently Asked Questions

Where can I download the annual report of Shilpa Medicare Ltd.?
Annual reports of Shilpa Medicare Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Shilpa Medicare Ltd.?
Quarterly earnings results and presentations of Shilpa Medicare Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Shilpa Medicare Ltd. publish earnings call transcripts?
Earnings call transcripts of Shilpa Medicare Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Shilpa Medicare Ltd.?
Investor presentations and annual day presentations of Shilpa Medicare Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Shilpa Medicare Ltd.?
Corporate announcements and regulatory filings of Shilpa Medicare Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Shilpa Medicare Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Shilpa Medicare Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Shilpa Medicare Ltd.?
The ISIN (International Securities Identification Number) of Shilpa Medicare Ltd. is INE790G01031. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Shilpa Medicare Ltd. listed?
Shilpa Medicare Ltd. is listed on NSE and BSE. The NSE symbol is SHILPAMED and the BSE code is -.
Where can I find the shareholding pattern of Shilpa Medicare Ltd.?
The quarterly shareholding pattern of Shilpa Medicare Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Shilpa Medicare Ltd. on Sharpely?
Share price data for Shilpa Medicare Ltd. is updated as of 15 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.